TRAVERE THERAPEUTICS INC. - COMMON STOCK
19.00
08-January-25 16:45:00
15 minutes delayed
Stocks
-0.08
-0.42%
Today's range
18.64 - 19.35
ISIN
N/A
Source
NASDAQ
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 Jul 2021 16:30:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics Announces Presentation of Abstracts at ERA-EDTA Congress 2021
04 Jun 2021 08:00:00 By Nasdaq GlobeNewswire
-
02 Jun 2021 08:00:01 By Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at Upcoming Investor Conferences
27 May 2021 16:30:00 By Nasdaq GlobeNewswire
-
25 May 2021 16:01:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics Reports First Quarter 2021 Financial Results
06 May 2021 16:01:02 By Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the BofA Securities 2021 Virtual Health Care Conference
27 Apr 2021 16:30:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics to Report First Quarter 2021 Financial Results
26 Apr 2021 16:30:00 By Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
01 Mar 2021 16:01:01 By Nasdaq GlobeNewswire
-
25 Feb 2021 08:00:02 By Nasdaq GlobeNewswire